Literature DB >> 15510034

Xylitol enhances bacterial killing in the rabbit maxillary sinus.

Christopher L Brown1, Scott M Graham, Benjamin B Cable, Egon A Ozer, Peter J Taft, Joseph Zabner.   

Abstract

OBJECTIVES: Factors that alter airway surface liquid (ASL) ionic concentrations may influence the course of sinusitis. Xylitol has been shown to effect ASL ionic composition in vitro and to reduce nasal bacterial carriage, otitis media, and dental caries in vivo. We examined the effect of xylitol on experimental sinusitis in the rabbit model. STUDY
DESIGN: Prospective randomized controlled study of xylitol, saline, and Pseudomonas aeruginosa administration to the rabbit maxillary sinus.
METHODS: P. aeruginosa was administered to the sinuses of 26 New Zealand white rabbits. Saline was placed in the left maxillary sinus and xylitol in the right. The rabbits were randomly assigned to one of three groups: one, simultaneous administration of bacteria and solutions with bacterial analysis at 20 minutes, 11 rabbits; two, preadministration of solutions 1 hour before bacterial infection with analysis at 20 minutes, 11 rabbits; three, established sinusitis, 4 rabbits had daily injections of solutions for 5 days starting 7 days after P. aeruginosa administration.
RESULTS: In group 1, 6.96% of injected bacteria were retrieved on the left (saline), whereas 0.095% were retrieved on the right (xylitol) (P = .034). In group 2, 5.64% of inoculum was recovered from the left and 2.89% from the right (P = .188). Group 3 demonstrated evidence of sinusitis with recovery of noninoculate bacteria. with no difference between right and left.
CONCLUSIONS: Xylitol reduces experimental sinusitis when administered simultaneously with bacteria. Its effect in established sinusitis is less clear. A role may exist for xylitol in nasal irrigation fluid in human disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15510034     DOI: 10.1097/01.mlg.0000147939.90249.47

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study.

Authors:  Behram Cam; Murat Sari; Ahmet Midi; Ozgül Gergin
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-29       Impact factor: 2.503

2.  Biofilms and inflammation in patients with chronic rhinosinusitis.

Authors:  Lavinia-Gianina Manciula; Ionut Isaia Jeican; Lucian Barbu Tudoran; Silviu Albu
Journal:  Med Pharm Rep       Date:  2020-10-25

3.  Genetic analysis of D-xylose metabolism by endophytic yeast strains of Rhodotorula graminis and Rhodotorula mucilaginosa.

Authors:  Ping Xu; Renata Bura; Sharon L Doty
Journal:  Genet Mol Biol       Date:  2011-07-01       Impact factor: 1.771

4.  Mupirocin in the Treatment of Staphylococcal Infections in Chronic Rhinosinusitis: A Meta-Analysis.

Authors:  Jong Seung Kim; Sam Hyun Kwon
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

Review 5.  Xylitol's Health Benefits beyond Dental Health: A Comprehensive Review.

Authors:  Krista Salli; Markus J Lehtinen; Kirsti Tiihonen; Arthur C Ouwehand
Journal:  Nutrients       Date:  2019-08-06       Impact factor: 5.717

6.  Symptom assessment after nasal irrigation with xylitol in the postoperative period of endonasal endoscopic surgery.

Authors:  Caroline Feliz Fonseca Sepeda da Silva; Flávia Emilly Rodrigues da Silva; Henrique Furlan Pauna; Johann Gustavo Guilhermo Melcherts Hurtado; Marco Cesar Jorge Dos Santos
Journal:  Braz J Otorhinolaryngol       Date:  2020-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.